Quantitative Evaluation of Severity of Coronary Artery Damage in Kawasaki Disease: Ultrasonic Tissue Characterization Method and Vascular Endothelial Growth Factor

被引:0
|
作者
Jun Furui
Masahiro Ishii
Yoko Sugahara
Wakako Himeno
Hiromi Muta
Yoshie Mizumoto
Daisaku Urabe
Teiji Akagi
Hirohisa Kato
机构
[1] Dept. of Pediatric Cardiology,
[2] St. Mary Hospital,undefined
[3] Dept. of Pediatrics,undefined
[4] Kurume Univ,undefined
[5] Dept. of Pediatrics,undefined
[6] St. Mary Hospital,undefined
来源
Pediatric Research | 2003年 / 53卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We evaluated the severity of coronary artery (CA) damage quantitatively by an ultrasonic tissue characterization (UTC) method and the plasma levels of vascular endothelial growth factor (VEGF) in patients (pts) with Kawasaki disease (KD), and determined the relationship between the incidence of coronary artery lesion (CAL) and those results. Forty pts with KD, (median age 2.8 years), 10 afebrile and 10 febrile controls, were studied. The 40 KD pts comprised 2 groups: Group A; 32 pts with no CAL, Group; 8 pts with CAL. The UTC of left CA wall was performed to measure the absolute echo-intensity (AEI) value. The AEI value of CA in subacute phase (SAP) (34± 3.2 dB) was significantly higher than acute (AP; 31± 1.7 dB) and convalescent phase (CP;32± 2.6dB). Kinetics of plasma VEGF levels showed similar trend, VEGF levels peaked in the SAP of KD (AP: 197± 60, SAP: 599± 411, CP: 271± 201 pg/ml, p < 0.05). The AEI values and plasma VEGF levels in KD pts in AP, before intravenous immune globulin (IVIG) treatment, were significantly higher than those in febrile (AEI: 18± 2.4dB, VEGF: 104± 36 pg/ml) and afebrile controls (AEI: 17± 1.5dB, VEGF 63± 33pg/ml, p < 0.05). Both AEI values and VEGF levels in AP in pts with CAL (Group B, AEI: 33± 2.0 dB, VEGF: 253± 35 pg/ml) were significantly higher than patients in Group A (AEI: 31± 1.4dB, VEGF: 184± 57 pg/ml, p < 0.05). The AEI value and VEGF levels peaked at the just before the developing of CAL. A significant correlation was found between AEI value and VEGF levels (r = 0.78, p < 0.05). Conclusion The UTC method and plasma VEGF levels may have potential as a predictor of incidence of CAL in pts with KD.
引用
收藏
页码:162 / 162
相关论文
共 50 条
  • [31] Kinetics of circulating plasma vascular endothelial growth factor in children with Kawasaki Disease
    Furui, J
    Ishii, M
    Ikeda, H
    Akagi, T
    Kato, H
    Kato, H
    Kato, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 469A - 470A
  • [32] Increased serum levels of vascular endothelial growth factor in Kawasaki disease.
    Maeno, N
    Shigemori, M
    Takei, S
    Masuda, K
    Akaike, H
    Nakae, Y
    Imanaka, H
    Matuo, K
    Kitajima, I
    Maruyama, I
    Miyata, K
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1524 - 1524
  • [33] Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease
    Takeshita, S
    Kawamura, Y
    Takabayashi, H
    Yoshida, N
    Nonoyama, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (03): : 575 - 579
  • [34] The Role of Vascular Endothelial Growth Factor B in a Mouse Model of Kawasaki Disease
    Ardelean, Daniela S.
    Duong, Trang T.
    Yeung, Rae
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 4011 - 4011
  • [35] Plasma vascular endothelial growth factor level is elevated in patients with multivessel coronary artery disease
    Nakajima, K
    Tabata, S
    Yamashita, Y
    Kusuhara, M
    Arakawa, K
    Ohmori, R
    Yonemura, A
    Higashi, K
    Ayaori, M
    Nakamura, J
    Ohsuzu, F
    CLINICAL CARDIOLOGY, 2004, 27 (05) : 281 - 286
  • [36] Further evidence for the contribution of the vascular endothelial growth factor gene in coronary artery disease susceptibility
    Cui, Q. T.
    Li, Y.
    Duan, C. H.
    Zhang, W.
    Guo, X. L.
    GENE, 2013, 521 (02) : 217 - 221
  • [37] Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease
    Henry, TD
    Rocha-Singh, K
    Isner, JM
    Kereiakes, DJ
    Giordano, FJ
    Simons, M
    Losordo, DW
    Hendel, RC
    Bonow, RO
    Eppler, SM
    Zioncheck, TF
    Holmgren, EB
    McCluskey, ER
    AMERICAN HEART JOURNAL, 2001, 142 (05) : 872 - 880
  • [38] Vascular Endothelial Growth Factor Polymorphisms and Extent of Coronary Atherosclerosis in Chinese Population With Advanced Coronary Artery Disease
    Lin, Tsung-Hsien
    Su, Ho-Ming
    Wang, Chiao-Ling
    Voon, Wen-Chol
    Shin, Shyi-Jang
    Lai, Wen-Ter
    Sheu, Sheng-Hsiung
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (09) : 960 - 966
  • [39] Disruption of vascular homeostasis in patients with Kawasaki disease: Involvement of vascular endothelial growth factor and angiopoietins
    Breunis, Willemijn B.
    Davila, Sonia
    Shimizu, Chisato
    Oharaseki, Toshiaki
    Takahashi, Kei
    van Houdt, Michel
    Khor, Chiea Chuen
    Wright, Victoria J.
    Levin, Michael
    Burns, Jane C.
    Burgner, David
    Hibberd, Martin L.
    Kuijpers, Taco W.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (01): : 306 - 315
  • [40] Vascular endothelial growth factor and coronary artery surgery: implications for improved endothelial protection!
    Chambers, DJ
    EUROPEAN HEART JOURNAL, 2000, 21 (20) : 1649 - 1651